P63 Expression in Hydropic Abortion and Gestational Trophoblastic Diseases

Placenta

Volumn 27, Issue 6-7, 2006, Pages 740-743

  Ramalho, L N Z ^a   Maggiori, M S ^a   Ribeiro Silva, A ^a   Peres, L C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gestational trophoblastic diseases; Hydropic abortion; Immunohistochemistry; p63

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROTEIN ANTIBODY; PROTEIN P63;

ABORTION; ARTICLE; CELLULAR DISTRIBUTION; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE FIXATION; TROPHOBLASTIC DISEASE;

ABORTION, SPONTANEOUS; ADULT; BIOLOGICAL MARKERS; CELL COUNT; CHORIOCARCINOMA; FEMALE; GESTATIONAL AGE; HUMANS; HYDATIDIFORM MOLE; MEMBRANE PROTEINS; PREGNANCY; STAINING AND LABELING; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 33646079853     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2005.05.006     Document Type: Article

References (23)

1. Li H.W., Tsao S.W., and Cheung A.N. Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 23 (2002) 20-31
2. Maisse C., Guerrieri P., and Melino G. p73 and p63 protein stability: the way to regulate function?. Biochem Pharmacol 66 (2003) 1555-1561
3. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2 (1998) 305-316
4. Signoretti S., Waltregny D., Dilks J., Isaac B., Lin D., Garraway L., et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157 (2000) 1769-1775
5. Di Como C.J., Urist M.J., Babayan I., Drobnjak M., Hedvat C.V., Teruya-Feldstein J., et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8 (2002) 494-501
6. Westfall M.D., and Pietenpol J.A. p63: molecular complexity in development and cancer. Carcinogenesis 25 (2004) 857-864
7. Reis-Filho J.S., Simpson P.T., Martins A., Preto A., Gartner F., and Schmitt F.C. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443 (2003) 122-132
8. Shih I.M., and Kurman R.J. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 28 (2004) 1177-1183
9. Au N.H., Gown A.M., Cheang M., Huntsman D., Yorida E., Elliott W.M., et al. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol 12 (2004) 240-247
10. Burstein D.E., Nagi C., Wang B.Y., and Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 35 (2004) 465-473
11. Hara T., Kijima H., Yamamoto S., Kenmochi T., Kise Y., Tanaka H., et al. Ubiquitous p63 expression in human esophageal squamous cell carcinoma. Int J Mol Med 14 (2004) 169-173
12. Hu W.F., Liu M.Q., and Zhao Q. Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance. Ai Zheng 23 (2004) 1021-1025
13. Gwosdz C., Balz V., Scheckenbach K., and Bier H. p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure. Adv Otorhinolaryngol 62 (2005) 58-71
14. Ivan D., Hafeez Diwan A., and Prieto V.G. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol 18 (2005) 137-142
15. Yu Y.W., Garber M.E., Schluns K., Pacyna-Gengelbach M., and Petersen I. Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray. Zhonghua Bing Li Xue Za Zhi 33 (2004) 324-327
16. Zigeuner R., Tsybrovskyy O., Ratschek M., Rehak P., Lipsky K., and Langner C. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Urology 63 (2004) 1079-1083
17. Paradinas F.J., Browne P., Fisher R.A., Foskett M., Bagshawe K.D., and Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 28 (1996) 101-110
18. Dietz S., Rother K., Bamberger C., Schmale H., Mossner J., and Engeland K. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett 525 (2002) 93-99
19. Vincek V., Knowles J., Li J., and Nassiri M. Expression of p63 mRNA isoforms in normal human tissue. Anticancer Res 23 (2003) 3945-3948
20. Kato H.D., Terao Y., Ogawa M., Matsuda T., Arima T., Kato K., et al. Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol 21 (2002) 255-260
21. Shiozaki A., Kataoka K., Fujimura M., Yuki H., Sakai M., and Saito S. Survivin inhibits apoptosis in cytotrophoblasts. Placenta 24 (2003) 65-76
22. Cheung A.N. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 17 (2003) 849-868
23. Howat A.J., Beck S., Fox H., Harris S.C., Hill A.S., Nicholson C.M., et al. Can histopathologists reliably diagnose molar pregnancy?. J Clin Pathol 46 (1993) 599-602